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Mammalian ribonucleases constitute one of the fastest evolving protein families in nature. The addi- 
tion of a four-residue carboxyl-terminal tail : Glu-Asp-Ser-Thr (EDST) in human pancreatic ribonuclease 
(HPR) in comparison with bovine pancreatic RNase (RNase A) could have adaptive significance in 
humans. We have cloned and expressed human pancreatic ribonuclease in Escherichiu coli to probe the 
influence of the four-residue extension and neighboring C-terminal residues on the biochemical properties 
of the enzyme. Removal of the C-terminal extension from HPR yielded an enzyme, HPR-(1 - 124)- 
peptide, with enhanced ability to cleave poly(C). HPR-(1 - 124)-peptide also exhibited a steep increase 
in thermal stability mimicking that known for RNase A. Wild-type HPR had significantly low thermal 
stability compared to RNase A. The study identifies the C-terminal boundary in the human pancreatic 
ribonuclease required for efficient catalysis. 
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Mammalian ribonucleases (RNases) constitute a ubiquitous 
superfamily of proteins with a high level of structural and func- 
tional divergence. Although the most obvious function of these 
enzymes is to degrade RNA, there is increasing evidence that 
they participate in many additional and more subtle biological 
processes apparently unrelated to routine RNA metabolism, 
earning them the designation RISBASEs (RNases with special 
biological actions ; D’ Alessio, 1993). Human pancreatic ribo- 
nuclease (HPR), unlike its bovine analog (RNase A), has been 
considered to be vestigeal in the non-ruminant human host 
where it is not required for the salvage of phosphorus from intes- 
tinal microflora (Barnard, 1969). Although HPR is present in 
very small amounts (10 pg/g tissue as compared to 1200 pg 
RNase A/g bovine pancreas) (Barnard, 1969), the faithful reten- 
tion of an enzyme for an apparently redundant function is intri- 
guing. 
Compared to RNase A, HPR contains a higher net proportion 
of basic residues (Sorrentino et al., 1992) and possesses substan- 
tial activity against double-stranded RNA (Bardon’ et al., 1976; 
Sorrentino and Libonati, 1994). While rigorously retaining ribo- 
nucleolytically essential Lys and His residues, HPR differs from 
RNase A, in the presence of a C-terminal extension of four resi- 
dues, Glu-Asp-Ser-Thr (EDST) beyond the terminal Val124 of 
RNase A. Although the carboxyl-terminal extension is known to 
arise as a result of a single base TAG-GAG mutation in the 
first termination codon in the open reading frame of HPR, the 
biological significance of the tetrapeptide tail is not known. The 
consequences of these differences could have relevance to the 
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in vivo function of HPR and would be interesting to evaluate in  
that light. The presence of almost identical C-terminal exten- 
sions in pancreatic RNases from a host of non-ruminating mam- 
mals (Beintema et al.. 1986) could be of significance in this 
respect. 
We have cloned and expressed the HPR gene in Escherichiu 
coli with an aim to analyze the role of the tetrapeptide extension 
and associated C-terminal residues in the enzymatic activity of 
HPR. The study reveals that the tetrapeptide C-terminal exten- 
sion is not necessary for ribonuclease activity; presence of 
additional residues beyond Asp1 21, implicated in catalysis, are 
detrimental to enzymatic activity. 
EXPERIMENTAL PROCEDURES 
Preparation of plasmid constructs for full-length and 
mutant HPRs. Mature HPR is a 128-amino-acid protein (Seno 
et al., 1994). The intronless 384-bp HPR gene was amplified 
from genomic DNA isolated from human blood by a 30-cycle 
hot-start PCR. Primers, H 1 (GTCCAGCCTTCCGCTAGCAAG- 
GAATCCCGG) and H2 (GCTCTGAATTCAGGTAGAGTCCT- 
CCACAGA), were designed to introduce an NheI restriction site 
on the 5’ end and an EcoRI site at the 3’ end, respectively, of 
the gene. The purified Nhe1-t EcoRI-restricted HPR DNA was 
inserted into PAP 110, digested with the same enzymes; PAP 
110 is a bacteriophage T7 promoter-based E. coli expression 
vector, containing a multiple cloning site, E. coli and phage ori- 
gin of replication and T7 transcription terminator. The resulting 
plasmid, designated as pHPR, has the 384-bp DNA encoding 
HPR under the T7 promoter. 
PCR was used to obtain genes encoding mutant HPR deriva- 
tives. pHPR was used as the template for constructing plasmids 
containing DNA encoding the mutants. Since all mutations were 
made at the C-terminus, a common 5’ primer, XUP (ACTCAC- 
TATAGGGAGACCAC) was designed using the vector sequence 
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at the 5' end of the T7 promoter sequence in pHPR. Primer H3 
(GGTAGGAATTCAGACAGAAGCATCAA) was used to con- 
struct plasmid pHPR(1- 124) lacking four C-terminal codons 
and primer H4 (AGCAGCCGAATTCAATCAAAGTGGACTG- 
GCAC), for plasmid pHPR(1- 121), lacking seven C-terminal 
codons of HPR. PCR products were purified and digested with 
XbaI and EcoRI, and ligated into pVex 11 that had been cleaved 
with the same enzymes; pVex 11 is a T7 bacteriophage promoter 
based vector similar to PAP 110. It is a high-copy-number plas- 
mid and is essentially different from PAP 110 only with respect 
to the multiple cloning site. The sequence at the beginning of 
the genes was 5'-ATG GCT AGC AAG GAA 3', introducing 
two additional residues, Ala and Ser, at the amino terminus of 
all proteins. The additional Ala and Ser residues at the N-termini 
of proteins arise from the Nhel site (GCT AGC), which is imme- 
diately downstream of the NdeI site (CAT ATG) in the vectors 
that provides the translation start. The underlined sequences 
represent the first two codons of HPR. Inserts were fully se- 
quenced to confirm correct integration of DNAs and the pres- 
ence of the desired mutations (Sanger et al., 1977). 
Expression and purification of recombinant HPR and its 
mutants. Initial screening for expression was performed in Lu- 
ria-Bertani medium; 5 ml of the medium containing 100 pg/ml 
sodium ampicillin was inoculated with a single colony of E. coli 
BL21(2DE3) containing the recombinant plasmid and grown at 
37°C in a gyratory shaker at 225 rpm. Expression of the recom- 
binant protein was induced at an absorbance at 600 nm of 1.0 
with 1 mM isopropyl P-D-thiogalactopyranoside. Cells were har- 
vested 90 min after induction and the periplasm was separated 
from spheroplast by cold osmotic shock. The separated fractions 
were electrophoresed on a 12.5 % SDS/polyacrylamide gel and 
visualized by Coomassie blue staining. HPR and its mutant 
forms were found to be present entirely in the insoluble form as 
inclusion bodies. Mutant proteins were prepared from 1-1 shake- 
flask cultures of E. coli BL21(iVDE3) grown in superbroth me- 
dium containing 100 pg/ml sodium ampicillin. Bacterial inclu- 
sion bodies containing the heterologous protein were prepared 
and recombinant proteins processed as described (Buchner et 
al., 1992). Protein was isolated from the inclusion bodies by 
denaturation in guanidine hydrochloride and renaturation in a 
buffer containing arginine and oxidized glutathione. Renatured 
protein was dialyzed against 20 mM Tris/HCl pH 7.4 and loaded 
onto an 8-ml S-Sepharose column (Pharmacia Biotech AB) at 
4°C equilibrated with 20 mM Tris/HCl pH 7.4. The protein was 
eluted from the column with a linear gradient of 0-1 M NaCl 
and fractions containing protein of the desired size, as detected 
by 125% SDSIPAGE, were pooled. Protein from the S-Sepha- 
rose column was further purified on a Spherogel TSK column 
(3000 SW, Beckman). Fractions containing monomeric protein 
were pooled, quantitated (Bradford, 1976) and stored frozen 
at -70°C for further experiments. 
Assay for enzymatic activity. RNase activity was assayed 
as described (Bond, 1988). Brietly, 40 pg RNA was incubated 
at 37°C with enzyme in a reaction buffer that consisted of 
100 mM Tris/HCI pH 7.5, 10 mM EDTA and 0.01 % acetylated 
BSA. The reaction was terminated after 60 min with 1 vol. cold 
3.16 M perchloric acid and 5.9 mM uranyl acetate and chilled 
on ice for 15 min. Unreacted high-molecular-mass RNA was re- 
moved by centrifugation at 15000Xg for 10 min and absorbance 
of supernatants at 260 nm was measured in a Varian DMS 100s 
ultraviolet/visible spectrophotometer after 1 :4 dilution into dis- 
tilled water. The absorbance of the blank reaction containing 
0.01 5% acetylated BSA in place of enzyme was subtracted from 
all the readings. Michaelis constants ( K J  with poly(C) substrate 
were determined for the enzymes from double-reciprocal plots 
of initial reaction velocities. 
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Fig. 1. Purification of recombinant HPR and mutant analogs used in 
the study. The genes encoding HPR and the indicated mutants were 
expressed in E. coli BL21(2DE3) and purified. Aliquots of 5 pg protein 
were then subjected to SDS/PAGE using 12.5% resolving gels and 
stained with Coomassie brilliant blue R 250. The position of molecular 
mass markers is shown on the left. Lane A, wild-type HPR; lane B, 
HPR-(l-I24)-peptide; lane C, HPR-(l-I21)-peptide. 
Assay for thermal stability. Full-length and mutant proteins 
in 0.01 % acetylated BSA were heated to 80°C for 40 min. in a 
dry-heat bath and RNase activity was assayed with poly(C) as 
described. Residual RNase activity was calculated with the ac- 
tivity of untreated enzymes taken as 100%. 
Circular dichroic measurements. CD spectra were re- 
corded at room temperature using a Jasco J 720 (Easton) dichro- 
graph equipped with a thermostated cell holder. A cell of 1 cm 
optical path length was used to record spectra of proteins in the 
far-ultraviolet region (250- 190 nm) at a protein concentration 
of 100 pg/3 ml in 10 mM sodium phosphate pH 7. Spectra were 
acquired at a scan speed of 50 n d m i n  with a sensitivity of 
50 mdeg and response time of 1 s. The sample compartment was 
purged with nitrogen and spectra were averaged over five scans. 
The solvent dichroic absorbance contribution was subtracted 
using the Jasco software. Secondary structures were calculated 
from the Jasco secondary structure estimation program based on 
reference parameters of Yang et al. (1 986). The thermal stability 
of wild-type HPR and HPR-( 1 - 124)kpeptide was evaluated by 
monitoring CD spectra in the far-ultraviolet region at temper- 
atures of 20, 37, 50, 65 and 80°C. Results are presented as mean 
residue ellipticity values [O], based on the amino acid mean resi- 
due mass of 110 Da. Bovine RNase A was included as a control. 
RESULTS 
High-yield purification of recombinant human pancreatic ri- 
bonuclease. We have expressed the HPR gene using a T7 pro- 
moter-based E. coli expression vector and report here an essen- 
tially two-step purification scheme that results in high yields 
of pure protein. The overexpressed protein was isolated from 
inclusion bodies, solubilized in guanidine . HCI and renatured 
in vitro using a glutathione-based refolding buffer. Recombinant 
HPR was subsequently purified to homogeneity by successive 
cation-exchange and gel-filtration chromatography. Purified re- 
combinant HPR migrated with an apparent molecular mass of 
16 kDa on a 12.5% SDS/PAGE (Fig. 1). Typical final yields of 
purified protein were in the range of 30-50 mg/l. Mutant forms 
of HPR were also cloned in the T7 promoter-based E. coli ex- 
pression vector. All proteins were localized in inclusion bodies 
in bacteria, and could be purified in similar fashion to homo- 
geneity with high yields (Fig. 1). 
Deletion of C-terminal EDST tail and ASVEDST enhances 
ribouuclease activity. The influence of the EDST extension in 
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Table 1. Comparative catalytic activity of HPR mutants. Ribo- 
nuclease activity of recombinant HPR and its derivatives was assessed 
using natural and synthetic RNA substrates. Values represent average of 
duplicate determinations with individual values not differing from each 
other by more than 10%. Amount of enzyme used40pg substrate = 
12.5-100 ng for poly(A) . poly(U), 0.0625-03 ng for poly(C) and 
0.125 - 1 ng for yeast tRNA. 
Enzyme Activity on 
poly(C) yeast tRNA poly(A) 
. POlY(U) 
AA,,,, . min-' . mg protein ' 
HPR (full-length) 214667 19067 330 
HPR-( 1 - 124)-peptide 1253 333 30400 1270 
HPR-(I - 121)-peptide 467200 24600 1350 
catalysis was studied with a mutant, HPR-(l- 124)-peptide lack- 
ing the four C-terminal amino acids. This peptide exhibited en- 
hanced ribonuclease activity as compared to HPR with all sub- 
strates tested (Table 1). Marked differences in RNase activities 
of HPR-( 1 - 124)-peptide were observed with the favored model 
substrate poly(C) and the double-stranded substrate, poly(A) 
. poly(U). Changes in activity profiles with yeast tRNA were 
less dramatic with only marginal increases in activity. Thus, 
while HPR-( 1 - 124)-peptide was almost 4 and 6 times as active 
as the wild-type enzyme on poly(C) and poly(A) . poly(U) re- 
spectively, it was only 1.6 times more active on yeast tRNA 
(Table 1). 
HPR-(1 - 121)-peptide, devoid of the seven carboxyl-termi- 
nal residues ASVEDST. also exhibited enhanced activity with 
all substrates tested (Table 1). As seen with the HPR-(1-124)- 
peptide, increase in activity was more pronounced with the 
favored substrate poly(C) and the duplex substrate poly(A) 
. poly(U), being respectively, 2 and 4 times more on these sub- 
strates. This mutant was only marginally (1.3 times) more active 
on yeast tRNA substrate (Table 1). Deletions beyond D121 re- 
sulted in complete inactivation of HPR (data not shown). 
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Fig. 2. CD spectra of HPR and mutant proteins. Far-ultraviolet spectra 
of recombinant proteins were recorded at 25°C; units are deg cm2 . 
dmol-'. Data was averaged over five scans. Bovine RNase A was in- 
cluded as a control. (---) HPR; (-) RNase A;  (. . . ' .) HPR-(1- 
124)-peptide; (- .-) HPR-(l-l21)-peptide. 
Michaelis constants (K,,,) for enzymes were derived from 
double-reciprocal plots of initial rates of reactions using poly(C) 
substrate. In 100 mM Tris/HCl pH 7.5, the K,,, values of the sub- 
strate, poly(C), were marginally higher for the HPR-(1 - 124)- 
peptide (1145 pM) and HPR-(I - 121)-peptide (920 pM) mu- 
tants as compared with the wild-type enzyme (881 pM). Re- 
moval of acidic residues (E, D) in the tetrapeptide extension may 
alter local charge distributions and facilitate release of cleaved 
ribonucleotides as an increase in K,, is reflected in the lowered 
affinity of substrate binding. 
Secondary structure analysis of HPR and mutants by CD. 
Far-ultraviolet CD spectra of HPR recorded at 25 "C showed 
negative ellipticities at 208, 217 and 222 nm and strong positive 
peaks in the region of 190 and 195 nm indicating that the protein 
possesses both a-helix and P-strand structure (Fig. 2). The a- 
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Fig.3. (A) Effect of thermal denaturation on the catalytic activity of HPR and its mutants and (B) change in helicity of proteins with 
increasing temperature. (A) Proteins were heated at 80°C and ribonuclease activity with poly(C) was assayed at various time points. Residual 
ribonuclease activity is indicated as a percentage of activity at time zero. Bovine RNase A was used as a control. (A) Full-length HPR; (0) HPR- 
(1 -124)-peptide; (m) HPR-(1 -121)-peptide; (7) RNdse A. (B) Far-ultraviolet spectra of proteins were recorded as a function of increasing 
temperature. Helicity was calculated from the mean residue ellipticity according to Morrisett et al. (1973) using the equation: 92 helicity = ([O]22Z- 
3000/-36000-3000)X100. (0) HPR; (M) HPR-(l-l24)-peptide; (A) RNase A. 
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helical content of HPR (17.45%), calculated according to Yang 
et al. (1986) appears to be higher than that of RNase A 
(10.60 %). Estimates of secondary structure elements for RNase 
A were in close agreement with reported values. The helical 
content of HPR was observed to decrease successively upon de- 
letion of four and seven C-terminal residues. This is in keeping 
with structure predictions by the method of Chou and Fasman 
(1974) which reveal that HPR possesses an additional helical 
region at the carboxyl terminus encompassing the eight terminal 
residues DASVEDST (data not shown). 
Deletion of C-terminal EDST enhances thermal stability. The 
HPR-(1 - 124)-peptide lacking C-terminal residues EDST was 
found to be more stable than the full-length protein towards heat 
denaturation. While the wild-type enzyme lost upto 60% of its 
activity when heated at 80°C for 40 min, HPR-(1-124)-peptide 
retained full activity at the end of 40 min. A similar effect was 
seen with the HPR-(1 - 121)-peptide lacking seven carboxyl-ter- 
minus residues ASVEDST. The thermal stability profiles of the 
mutant constructs are comparable to those of RNase A, which 
is known to be stable at high temperatures (Fig. 3A). 
Evaluation of thermal stability of HPR mutants by CD. Ther- 
mal unfolding of HPR, HPR-( 1 - 124)-peptide and RNase A was 
evaluated by monitoring changes in CD spectra in the far-ultra- 
violet range (250-190 nm). Marked deviation in absorption 
pattern of HPR at SO "C in comparison to HPR-( 1 - 124)-peptide 
and RNase A indicates loss of considerable secondary structure. 
HPR underwent upto 30% and 5 0 %  decrease in helical content 
at 50°C and 65 "C, respectively, whereas the helical contents of 
HPR-(1- 124)-peptide or RNase A were not drastically a€fected 
upto 65 "C (Fig. 3 B). This suggests that unfolding occurs earlier 
or at a faster rate in HPR than in HPR-(l-l24)-peptide or 
RNase A. 
DISCUSSION 
The T7-promoter based E. coli expression system was used 
to obtain high-level expression of human pancreatic ribo- 
nuclease. Earlier, HPR has been expressed in mammalian cells 
(Russo et al., 1993) and, more recently in E. coli, cloned down- 
stream of the T7 promoter (Futami et al., 1995). However, the 
investigators have employed a complicated down-stream pro- 
cessing protocol to purify the enzyme from E. coli and obtain 
low levels of the purified product, 1.1 - 1.2 mg/l. Analysis of 
CD spectra of HPR indicated a similar overall organization of 
backbone structure as RNase A, albeit with a higher helical 
content. These observations suggest that the renaturation process 
employed in this study for purification of recombinant HPR 
yields correctly folded protein. Further, the presence of two N- 
terminal residues, Ala and Ser, introduced as a consequence of 
the strategy used for cloning do not appear to be detrimental to 
the conformation or the enzymatic activity of the protein. 
This study reveals that the EDST extension is not essential 
for ribonuclease activity of HPR. It appears, however, to modu- 
late the biochemical behavior of the enzyme. Thus, removal of 
the tetrapeptide extension enhanced enzymatic activity over that 
of the wild-type enzyme. This mutant has a carboxyl terminus 
that is identical to that present in RNase A. CD spectral analysis 
predicts similar distribution of secondary structural elements in 
HPR-(l-l24)-peptide and RNase A and the increase in activity 
observed with HPR-( 1 - 124)-peptide reflects a shift towards a 
structure more like RNase A. Presence of additional C-terminal 
residues beyond Asp121 in HPR are detrimental to RNase 
activity. 
In addition, compared to RNase A, wild-type HPR was 
found to be a thermolabile ribonuclease. HPR-( 1 - 124)-peptide, 
in contrast, exhibited enhanced thermostability mimicking that 
observed in RNase A ;  HPR-(l-l21)-peptide also exhibited en- 
hanced thermal stability of the same order. The presence of neg- 
atively charged residues, Glu125 and Asp126, near the carboxyl 
terminus of HPR may lead to destabilization of the C-terminal 
helix according to the helix dipole model (Shoemaker et al., 
1985) and contribute to decreased stability of the wild-type pro- 
tein. In addition, these extra residues may hinder efficient fold- 
ing in the P-sheet region encompassing residues 105-124 
known in RNase A to contain a primary chain folding initiation 
site (Beak et al., 1991). Beak et al. (1991) have further reported 
stabilization of a 20-amino-acid peptide consisting of the RNase 
A cluster 105 - 124 (HIIVACEGNPYVPVHFDASV), which 
was identified as a nucleation site, as a result of intramolecular 
hydrophobic interactions. The hydrophobic interactions ob- 
served in this stretch were found to be sufficient to direct the 
partial folding of the peptide. Deletion of four C-terminal resi- 
dues from HPR would eliminate the restrictive/destabilizing 
forces and enable the carboxyl terminus chain-folding initiation 
site to function optimally and lead to a folded structure that re- 
sembles that of RNase A. 
An extended carboxyl-terminus, similar to that present in 
HPR, has been observed in pancreatic RNases from a number 
of mammalian orders (Beintema et at., 1986). Curiously, these 
are present only in mammals with a non-ruminant habit. An 
EDST-like extension, for instance, is found in pancreatic RNase 
from langur (P entellus) and sloth (C. hoffmanii and B. infusca- 
tus), whereas some of its degenerate forms: EVST, GPST and 
EPST are found respectively in horse (E. cuballus), porcupine 
(H.  cristata), and guinea pig (C. porcellus) and capybara (H. 
Izydrochaeris). Although a definitive role for the retention of the 
pancreatic ribonuclease in the human host has not been found, 
it is possible that HPR plays a role in mammalian physiology 
in addition to RNA digestion; the presence of the tetrapeptide 
extension may be of significance in this respect. 
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